Lobular carcinoma in situ of breast: Understanding the Condition
Lobular carcinoma in situ (LCIS) of the breast is a non-invasive condition that affects the lobules or milk-producing glands in the breast. It is not a type of breast cancer but it increases the risk of developing invasive breast cancer in the future.
LCIS is a rare condition and is usually detected during routine breast cancer screening or biopsy. It is more common in women who are in their 40s or 50s and those who have a family history of breast cancer.
Symptoms of LCIS
LCIS does not cause any symptoms and is usually detected during routine breast cancer screening or biopsy. However, some women may notice lumps or thickening in their breasts or experience discharge from the nipples.
Treatment of LCIS
LCIS does not require immediate treatment but it is important to monitor the condition closely and undergo regular breast cancer screenings. The treatment options for LCIS include:
- Close monitoring: Women with LCIS are advised to undergo regular breast cancer screenings to detect any changes in the breast tissue.
- Medication: Some women may be prescribed medication such as tamoxifen or raloxifene to reduce the risk of developing invasive breast cancer.
- Surgery: In some cases, women may choose to undergo prophylactic mastectomy (removal of one or both breasts) to reduce their risk of developing breast cancer.
Prevention of LCIS
There is no sure way to prevent LCIS but there are steps you can take to reduce your risk of developing breast cancer. These include:
- Eating a healthy diet and maintaining a healthy weight
- Exercising regularly
- Limiting alcohol consumption
- Not smoking
- Undergoing regular breast cancer screenings
If you have been diagnosed with LCIS, it is important to talk to your doctor about your treatment options and ways to reduce your risk of developing invasive breast cancer. With proper monitoring and care, women with LCIS can live a healthy, normal life.